Risk | Very High |
---|---|
Min SIP Amount | ₹500 |
Expense Ratio | 2.59% |
NAV | ₹14.05 (22 Apr 2021) |
---|---|
Fund Started | 25 Jan 2017 |
Fund Size | ₹188 Cr |
Name | Sector | Instrument | % Assets |
---|---|---|---|
Astral Ltd. | Chemicals | Equity | 3.7% |
Dalmia Bharat Ltd. | Construction | Equity | 3.6% |
Supreme Industries Ltd. | Chemicals | Equity | 3.5% |
PI Industries Ltd. | Chemicals | Equity | 3.3% |
Gujarat Gas Ltd. | Chemicals | Equity | 3.3% |
Crompton Greaves Consumer Electricals Ltd. | Cons Durable | Equity | 3.0% |
The Ramco Cements Ltd. | Construction | Equity | 3.0% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 2.9% |
Muthoot Finance Ltd. | Financial | Equity | 2.7% |
ACC Ltd. | Construction | Equity | 2.7% |
IDBI Midcap Fund Regular Growth is a Equity Mutual Fund Scheme launched by IDBI Mutual Fund. This scheme was made available to investors on 25 Jan 2017. Ashish Mishra is the Current Fund Manager of IDBI Midcap Fund Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹188 Cr and the Latest NAV as of 22 Apr 2021 is ₹14.05.
The IDBI Midcap Fund Regular Growth is rated Very High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 12 months.
The scheme seeks to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Midcap Companies.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.